Envestnet Portfolio Solutions Inc. raised its position in shares of The Allstate Corporation (NYSE:ALL - Free Report) by 12.2% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 52,846 shares of the insurance provider's stock after purchasing an additional 5,739 shares during the period. Envestnet Portfolio Solutions Inc.'s holdings in Allstate were worth $10,639,000 as of its most recent filing with the Securities and Exchange Commission.
Other institutional investors and hedge funds have also bought and sold shares of the company. Price T Rowe Associates Inc. MD boosted its holdings in shares of Allstate by 25.4% in the first quarter. Price T Rowe Associates Inc. MD now owns 11,709,610 shares of the insurance provider's stock worth $2,424,710,000 after acquiring an additional 2,374,684 shares during the period. Boston Partners boosted its holdings in shares of Allstate by 613.9% in the first quarter. Boston Partners now owns 2,482,654 shares of the insurance provider's stock worth $512,627,000 after acquiring an additional 2,134,893 shares during the period. Goldman Sachs Group Inc. boosted its holdings in shares of Allstate by 27.2% in the first quarter. Goldman Sachs Group Inc. now owns 2,328,070 shares of the insurance provider's stock worth $482,073,000 after acquiring an additional 497,982 shares during the period. Strs Ohio bought a new position in shares of Allstate in the first quarter worth $84,408,000. Finally, AQR Capital Management LLC boosted its holdings in shares of Allstate by 20.3% in the first quarter. AQR Capital Management LLC now owns 2,018,403 shares of the insurance provider's stock worth $417,244,000 after acquiring an additional 340,150 shares during the period. 76.47% of the stock is owned by institutional investors.
Allstate Price Performance
NYSE:ALL opened at $205.80 on Tuesday. The firm has a market capitalization of $54.23 billion, a price-to-earnings ratio of 9.68, a P/E/G ratio of 0.78 and a beta of 0.38. The Allstate Corporation has a 52-week low of $176.00 and a 52-week high of $215.70. The stock has a fifty day moving average of $206.12 and a 200 day moving average of $201.01. The company has a debt-to-equity ratio of 0.37, a quick ratio of 0.43 and a current ratio of 0.43.
Allstate (NYSE:ALL - Get Free Report) last posted its quarterly earnings data on Wednesday, July 30th. The insurance provider reported $5.94 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.20 by $2.74. Allstate had a return on equity of 28.74% and a net margin of 8.79%.The company had revenue of $15.05 billion during the quarter, compared to analyst estimates of $16.59 billion. During the same quarter last year, the company earned $1.61 earnings per share. The firm's quarterly revenue was up 5.8% on a year-over-year basis. On average, research analysts expect that The Allstate Corporation will post 18.74 EPS for the current fiscal year.
Analyst Upgrades and Downgrades
A number of equities analysts have recently commented on the company. BMO Capital Markets raised their price target on Allstate from $230.00 to $235.00 and gave the stock an "outperform" rating in a report on Wednesday, August 20th. Raymond James Financial reaffirmed a "strong-buy" rating and issued a $260.00 price target (up from $250.00) on shares of Allstate in a report on Monday, August 4th. Roth Capital set a $230.00 price target on Allstate and gave the stock a "buy" rating in a report on Friday, September 26th. Jefferies Financial Group raised their price target on Allstate from $254.00 to $255.00 and gave the stock a "buy" rating in a report on Monday, August 11th. Finally, Wolfe Research raised Allstate to a "strong-buy" rating in a research note on Tuesday, September 16th. Two equities research analysts have rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, Allstate presently has a consensus rating of "Moderate Buy" and a consensus price target of $234.50.
View Our Latest Analysis on Allstate
Allstate Company Profile
(
Free Report)
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Allstate, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Allstate wasn't on the list.
While Allstate currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.